Anti-MDA5 antibodies are detected in 30-50% of dermatomyositis-associated ILD cases, often presenting as clinically amyopathic dermatomyositis with minimal muscle involvement but rapidly progressive lung injury [6-8]. Here, IFIH1 is linked to interstitial lung disease.